Several studies have shown that the intraperitoneal injection of LPS upregulates the expression of proinflammatory cytokines, including IL-1β, IL-6, and TNF-α, leading to anxiety, depression, and cognitive deficits (Huang et al., 2020; Chen et al., 2021). Here, TNF is linked to depressive symptom measurement.